Skip to content

The Australian CareLink Quality and Impact of Remote Follow-Up Evaluation Study (The ACQUIRE Study); to assess time and financial burden for device follow-up in patients with a pacemaker, implantable cardioverter defibrillator or cardiac resynchronisation therapy device.

The ACQUIRE Study: To assess the impact of remote device follow-up on time and financial burden in patients with a pacemaker, implantable cardioverter defibrillator or cardiac resynchronisation therapy device.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12607000517471
Acronym
The ACQUIRE Study
Enrollment
225
Registered
2007-10-09
Start date
2007-11-16
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Cardiology patients who receive an implanted device (pacemaker, implantable cardioverter defibrillator or cardiac resynchronisation therapy device) return to their doctor on a regular basis to have their device interrogated and followed-up. There is a new method of following-up these devices from the patient’s home called the Medtronic CareLink Network. Patients use a Monitor to interrogate their implanted device (that is, to collect information from the device using the antenna attached to the Monitor). The monitor then uses an analogue “landline” to send the encrypted data to the central database. Clinicians can access the information from the patient’s implanted devices by logging into the secure, password-protected Website. The goal of the ACQUIRE Study is to assess the impact of remote device monitoring on time and financial burden for patients, clinicians and clinics themselves. Furthermore, the acceptance, ease of use, satisfaction and impact of the system will be assessed for both patients and clinicians, respectively. The time and financial impact will be investigated in order to better understand the potential value to economic stakeholders. The economic stakeholders include patients, caregivers, clinicians, and health care systems.

Interventions

The Medtronic CareLink Network is a system which allows patients with a CareLink monitor, to transmit data from their implanted device to their doctor directly from home using their phone line. Over 9 months a combination of clinic visits and CareLink transmissions will occur allowing comparison of the characteristics of the 2 methods for device follow-up.

Sponsors

Medtronic Australasia Pty Ltd
Lead SponsorCommercial sector/Industry

Eligibility

Sex/Gender
All
Age
18 Years to -2147483648 No limit
Healthy volunteers
No

Inclusion criteria

Patient is scheduled to receive (or has a previously implanted) IPG, ICD or CRT device that is supported by the Medtronic CareLink Network. Patient has access to a telephone line where they reside, and are willing and able to use the Medtronic CareLink Monitor and perform the required duties at home or have a family member or assistant perform those duties. Patient signs the study consent form and agrees to comply with all study requirements

Exclusion criteria

Patient is enrolled in, or intends to participate in, another clinical trial that might conflict with this study. Patient has medical conditions that would limit study participation (e.g. hearing or speech impaired with no family member or assistant available).

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026